Antibiotic Treatment for Pediatric Cellulitis of Skin Wounds

First-Line Antibiotic Selection

• The American Academy of Pediatrics recommends beta-lactam monotherapy with cephalexin or dicloxacillin as the standard of care for children with uncomplicated cellulitis of a skin wound, which is successful in 96% of cases, and MRSA coverage should NOT be added routinely 1, 2
• Cephalexin 25-50 mg/kg/day divided into 3-4 doses provides excellent coverage against streptococci and methicillin-sensitive Staphylococcus aureus 1, 2

Treatment Duration

• The Infectious Diseases Society of America recommends treating for exactly 5 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe 1, 2
• There is no evidence that 10-day courses are superior to 5-7 day courses for uncomplicated cellulitis 2

When to Add MRSA Coverage

• The American Academy of Pediatrics recommends adding MRSA coverage ONLY when specific risk factors are present, such as penetrating trauma or injection drug use, purulent drainage or exudate, evidence of MRSA infection elsewhere or known nasal colonization, systemic inflammatory response syndrome (SIRS) with fever, tachycardia, or altered mental status, or failure to respond to beta-lactam therapy after 48-72 hours 1, 2

MRSA-Active Oral Regimens for Children

• The Infectious Diseases Society of America recommends clindamycin 10-13 mg/kg/dose every 6-8 hours, trimethoprim-sulfamethoxazole 4-6 mg/kg/dose twice daily PLUS a beta-lactam, or doxycycline 2 mg/kg/dose twice daily PLUS a beta-lactam for children >8 years and <45 kg when MRSA coverage is indicated 1, 2

Penicillin Allergy Considerations

• The American Academy of Pediatrics recommends clindamycin 10-13 mg/kg/dose every 6-8 hours as the preferred alternative for children with documented penicillin allergy, providing coverage for both streptococci and MRSA if local resistance is low 1, 2

Hospitalization and IV Therapy

• The Infectious Diseases Society of America recommends hospitalizing children with cellulitis who have age <6 months with moderate-to-severe disease, SIRS criteria, hypotension or altered mental status, severe immunocompromise or neutropenia, or concern for deeper or necrotizing infection 1, 2
• Vancomycin 15 mg/kg IV every 6 hours is first-line for complicated cellulitis requiring hospitalization (A-II evidence) 1, 2

Special Considerations for Minor Infections

• The American Academy of Pediatrics recommends mupirocin 2% topical ointment for children with minor skin infections such as impetigo and secondarily infected lesions (eczema, ulcers, lacerations) (A-III evidence) 1

Critical Pitfalls to Avoid

• The Infectious Diseases Society of America recommends never using tetracyclines (doxycycline, minocycline) in children <8 years of age due to tooth discoloration and bone growth effects (A-II evidence) 1, 2
• Do not routinely add MRSA coverage for typical nonpurulent cellulitis without specific risk factors, as this represents overtreatment and increases antibiotic resistance 1, 2

Essential Adjunctive Measures

• The American Academy of Pediatrics recommends elevating the affected extremity above heart level to promote gravity drainage of edema and inflammatory substances, examining interdigital toe spaces for tinea pedis, fissuring, or maceration, keeping draining wounds covered with clean, dry bandages, and maintaining good hand hygiene 1, 2